Ashok Sharma
Cardiovascular Disease · Mahwah, NJNPI 1497804405
Payments from drug & device makers
Across 95 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$333
- Johnson & Johnson$258
- Amgen$183
- E.r. Squibb & Sons, L.L.C.$168
- Pharmacyclics LLC, An Abbvie Company$101
- AbbVie$93
- plus $674 from 23 others
What the payments were for
- Food & beverage$1,810100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $333 |
| Johnson & Johnson(2 entities) | 14 | $258 |
| Amgen | 12 | $183 |
| E.r. Squibb & Sons, L.L.C. | 12 | $168 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $101 |
| AbbVie | 4 | $93 |
| Eisai Inc. | 5 | $88 |
| AstraZeneca(2 entities) | 5 | $74 |
| Bristol Myers Squibb | 5 | $66 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Incyte Corporation | 3 | $45 |
| Boehringer Ingelheim | 3 | $42 |
| Bayer | 2 | $33 |
| Pfizer | 2 | $27 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Spectrum Pharmaceuticals Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Seagen Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $15 |
| EUSA Pharma (US) LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$333
How this compares
$1,810 in reported general payments places this provider in the 35th percentile of 1,006 cardiovascular disease providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $129 |
| Amlodipine Besylate | 19 | $102 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Mahwah
- Robert KippermanMorristown$5.3M
- Sharan MahalBridgewater$3.5M
- Linda GillamMorristown$2.2M
- Mark GelerntHaddon Heights$2M
- Robert FishbergSpringfield$1.9M
- Dilip ViswanathHaddon Heights$1.8M
- Marc CohenNewark$1M
- Jasjit WaliaElizabeth$859K
- Sajjad SabirCamden$742K
- John CovaleskyManalapan$716K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.